Monopar Therapeutics·4

Jul 2, 7:38 PM ET

Vu Quan Anh 4

4 · Monopar Therapeutics · Filed Jul 2, 2026

Research Summary

AI-generated summary of this filing

Updated

Monopar (MNPR) CFO Vu Quan Anh Receives 1,228 RSUs; 507 Withheld

What Happened

  • Vu Quan Anh, Chief Financial Officer of Monopar Therapeutics (MNPR), had 1,228 restricted stock units (RSUs vest) converted into common shares on June 30, 2026. To cover withholding taxes, 507 of those shares were surrendered to the issuer for tax payment (reported value $92.59/share; $46,943 total). The net result was an increase of 721 shares to his holdings.
  • This was an award/vesting transaction (not an open-market buy or sale). The gross value of the 1,228 vested shares at $92.59 was about $113,701 before tax withholding.

Key Details

  • Transaction date: 2026-06-30 (Form filed 2026-07-02).
  • Vesting/conversion: 1,228 RSUs converted to 1,228 common shares (derivative exercise/settlement).
  • Tax withholding: 507 shares withheld at $92.59/share for $46,943 (code F — tax payment).
  • Net shares received: 721 shares (1,228 − 507), approx. $66,757 at $92.59/share.
  • Shares owned after transaction: Not disclosed in this Form 4.
  • Footnotes: The shares came from a Dec 2, 2025 grant of 9,826 RSUs vesting 6/48ths (1,228) on 6/30/2026 and 614 shares every three months thereafter through 12/31/2029. Withheld shares were surrendered to cover tax withholding upon vesting.

Context

  • This was a routine vesting/settlement of RSUs with shares withheld to satisfy tax obligations (a common practice that does not indicate an open-market sale or purchase).
  • No 10b5-1 or gift indication; not an exercise-for-sale—shares were not sold on the open market.

Insider Transaction Report

Form 4
Period: 2026-06-30
Vu Quan Anh
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-06-30+1,2282,728 total
  • Tax Payment

    Common Stock

    [F2]
    2026-06-30$92.59/sh507$46,9432,221 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F3]
    2026-06-301,2288,598 total
    Common Stock (1,228 underlying)
Footnotes (3)
  • [F1]Represents shares acquired on vesting and settlement of restricted stock units.
  • [F2]Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
  • [F3]On December 2, 2025, the reporting person was granted 9,826 restricted stock units, vesting 6/48ths (1,228) on June 30, 2026, and 3/48ths (614 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2029. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
Signature
/s/ Quan Vu|2026-07-02

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4